A perspective of pemphigus from bedside and laboratory-bench

Clinical Reviews in Allergy and Immunology

Volumn 33, Issue 1-2, 2007, Pages 57-66

  Kitajima, Yasuo ^a   Aoyama, Yumi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Desmogleins; Desmosomes; Pemphigus; Signaling

Indexed keywords

DESMOGLEIN; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G; AUTOANTIBODY; DESMOGLEIN 1; DESMOGLEIN 3;

AUTOIMMUNE DISEASE; BLISTER; DISEASE CLASSIFICATION; HUMAN; IMMUNOPATHOGENESIS; LABORATORY DIAGNOSIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; POINT OF CARE TESTING; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; CELL ADHESION; CLASSIFICATION; DESMOSOME; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; AUTOANTIBODIES; CELL ADHESION; DESMOGLEIN 1; DESMOGLEIN 3; DESMOSOMES; HUMANS; PEMPHIGUS;

EID: 39649101736     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0036-5     Document Type: Review

References (64)

1. MacGrath JA (2005) Inherited disorders of desmosomes. Aust J Dermatol 46:221-229
2. Kitajima Y (2002) Mechanisms of desmosome assembly and disassembly. Clin Exp Dermatol 27:684-690
3. Stanley JR (1992) Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Advances in immunology. Adv Immunol 53:291-325
4. Amagai M (1999) Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20:92-102
5. Kitajima Y (2003) Current and prospective understanding of clinical classification, pathomechanisms and therapy in pemphigus. Arch Dermatol Res 295:S17-S23
6. Stanley JR (2003) Pemphigus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S (eds) Dermatology in general medicine. McGraw-Hill, New York, NY, pp 558-567
7. Amagai M, Komai A, Hashimoto T, Shirakata Y, Yamada T, Kitajima Y, Ohya KH, Nishikawa T (1999) Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140:351-357
8. Amagai M (1996) Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 11:319-352
9. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461-468
10. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR (2000) Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6:1275-1277
11. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nisshikawa T (1995) Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 105:243-247
12. Anhalt GJ, Jim SS, Stanley C Jr, Korman Nj, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Ariss-Abdo L (1990) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 323:1729-1735
13. Wade MS, Black MM (2005) Paraneoplastic pemphigus: a brief update. Aust J Dermatol 46:1-10
14. Jablonska S, Chorzelski TP, Beutner EH, Jarzabek-Chorzelsska M (1975) Immunologic phenomena in herpes gestations. Their pathogenic and diagnostic significance. J Dermatol 14:353-359
15. Ishii K, Amagai M, Kaomai A, Ebihara T, Chorzelki TP, Jabronska S (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135:943-947
16. Hashimoto T, Inamoto N, Nakamura K, Noishikawa T (1987) Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis. Arch Dermatol 123:1062-1065
17. Hashimoto T, Kiyokawa C, Mori O, Miyasato M, Chidgey MA, Garrod DR (1997) Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 109:127-131
18. Morizane S, Yamamoto T, Hisamatsu Y, Tsuji K, Oono T, Hashimoto T, Iwatsuki K (2005) Pemphigus vegetans with IgG and IgA antidesmoglein 3 antibodies. Br J Dermatol 153:1236-1237
19. Hisamatsu Y, Amagai M, Garrod DR, Kanzaki T, Hashimoto T (2004) The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus. Br J Dermatol 151:73-83
20. Ahmed AR, Blose DA (1984) Pemphigus vegetans. Neumann type and Hallopeau type. Int J Dermatol 23:135-141
21. Tsunoda K, Oita T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170:2170-2178
22. Kricheli D, David M -Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, Milner Y (2000) The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 143:237-238
23. Nguyen VT, Arredondo J, Chernyavssky AI, Kitajima Y, Pittelkow M, Grando SA (2004) Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 279:2135-2146
24. Nguyen VT, Arredondo J, Chernyavssky AI, Pittelkow M, Kitajima Y, Grando SA (2004) The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 140:327-334
25. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando S (2000) Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 106:1467-1479
26. Nguyen VT, Ndoye A, Grando SA (2000) Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 275:29466-29476
27. Grando SA (2000) Autoimmunity to keratinocyte acethylcholin receptors in pemphigus. Dermatology 201:290-295
28. Grando SA (2006) Cholinergic control of epidermal cohesion. Exp Dermatol 15:265-287
29. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115:889-899
30. Kitajima Y, Aoyama Y, Seishima M (1999) Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell detachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. J Invest Dermatol Symp Proc 4:137-144
31. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091-1110
32. Pulkkinen L, Choi YW, Simpson A, Montagutelli X, Sundberg J, Uitto J, Mahoney MG(2002) Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene. J Invest Dermatol 119:1237
33. Stanley JR (2000) The pathophysiology of pemphigus. J Dermatol Sci 24:155-157
34. 2+ concentration. J Invest Dermatol 89:167-171
35. Kitajima Y, Tsujimura Y, Sato M, Yamaguchi F, Aoyama Y (2001) Evidence that pemphigus vulgaris IgG causes no steric hindrance in desmosome formation, but forms desmoglein 3-deficiebt desmosomes. J Invest Dermatol 117:406 (abstract)
36. Aoyama Y, Owada MK, Kitajima Y (1999) A pathogenic autoantibody, pemphigus IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 29:2233-2240
37. Aoyama Y, Kitajima Y (1999) Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3(Dsg3) from the triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 112:67-71
38. Kawasaki Y, Aoyama Y, Tsunoda K, Amagai M, Kitajima Y (2006) Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK Phosphorylation in human squamous carcinoma cell line. Autoimmunity 39:587-590
39. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubinstggein DS (2005) Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 280(23):23778-23784
40. Aoyama Y, Kanno M, Nagai M, Yamamoto Y, Ozawa M, Kitajima Y (2006) The cytoplasmic membrane-proximal region of desmoglein 3 is critical for p120ctn binding to desmoglein 3. J Invest Dermatol 126:32 (abstract)
41. Kawasaki Y, Aoyama Y, Tsunoda K, Amagai M, Kitajima Y (2006) Different anti-desmoglein 3 monoclonal antibodies exert epitope-specific regulation of p120 catenin phosphorylation and of p120 catenin binding to desmoglein 3 in human squamous cell carcinoma cell line, DJM-1 cells. J Invest Dermatol 126:6 (abstract)
42. Caldelari R, de Bruin A, Boumann D, Suter MM, Bierkamp C, Balmer V, Muller E (2001) A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 153:823-834
43. Puviani M, Marconi A, Cozzani E, Pincelli C (2003) Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 120:164-167
44. Wang X, Brégégère F, Soroka Y, Frusic-Zlotkin M, Milner Y (2004) Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes. FEBS Lett 567:281-286
45. Arredondo J, Chernyavsky AI, Karaouni A, Grando SA (2005) Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus. Am J Pathol 167:1531-1544
46. Willamson L, Raess N, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25:3298-3309
47. Hashimoto K, Shafran KM, Webber PA, Lazarus GS, Singer KH (1983) Anti-cell surface pemphigus antibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259-272
48. Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y (1995) Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 105:329-333
49. Hashimoto K, Wun T-C, Baird J, Lazarus GS, Jensen PJ (1989) Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 92:310-315
50. Mahoney MG, Wang ZH, Stanley JR (1999) Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 113:22-25
51. Sato M, Aoyama Y, Kitajima Y (2000) Assembly pathway pf desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 80:1583-1592
52. Shu E, Yamamoto Y, Sato-Nagai M, Aoyama Y, Kitajima Y (2005) Pemphigus vulgaris-IgG reduces the desmoglein 3/desmocollin 3 ratio on the cell surface in cultured keratinocytes as revealed by double-staining immunoelectron microscopy. J Dermatol Sci 40:209-211
53. Calkins C, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006) Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 281:7623-7634
54. Cirillo N, Femiano F, Gombos F, Lanza A (2006) Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 580:3276-3281
55. Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai K, Kitajima Y (2007) Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 282:17866-17876
56. Shu E, Yamamoto Y, Aoyama Y, Kitajima Y (2007) Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis. Arch Dermatol Res 299:165-167
57. O'Toole EA, Mak LL, Guitart J, Woodley DT, Hashimoto T, Amagai M, Chan LS (2000) Induction of keratinocyte interleukin-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 119:217-224
58. Nishifuji K, Anagai M, Kuwana T, Iwassaki T, Nishikawa T (2000) Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol 114:88-94
59. Veldman CA, Stauber R, Wasssmuth W, Ulter W, Schuler G, Hertl M (2003) Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 170:635-642
60. Veldman CA, Gebhard K, Ulter W, Wasssmuth W, Goetzinger J, Hertl (2003) T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 172:3883-3892
61. Veldman CA, Hohne D, Dieckman G, Schuler G, Hertl (2004) Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 172:6468-6475
62. Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M (2006) Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 176:3215-3222
63. Hertl M, Eming R, Veldman C (2006) T cell control in autoimmune bullous skin disorders. J Clin Invest 116:1159-1166 (review)
64. Amagai M, Ahmed RA, Kitajima Y, Brystryn JC, Milner Y, Gniadecki R, Hertle M, Pincelli C, Fridkis-Hareli M, Aoyama Y, Frsic-Zoltkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S (2006) Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? Exp Dermatol 15:815-831